Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
1 "Public health insurance"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries
Shu Chen Wei
Intest Res 2016;14(3):218-223.   Published online June 27, 2016
DOI: https://doi.org/10.5217/ir.2016.14.3.218
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

The cost of caring for patients with inflammatory bowel disease (IBD) is high. Without government support, the cost burden will unavoidably rest on the patients and their family. However, the government providing full support will place a large financial burden on the health-care systems of a country. The aim of this study is to understand the current status of public medical insurance systems in caring for IBD patients among Asian countries.

Methods

Questionnaires inquiring about the availability of public health systems; medical, diagnostic, and endoscopy costs; and coverage rate of biologics use were designed and sent to IBD experts in each of the Asian countries studied. The results were summarized according to the feedback from the responders.

Results

The public health insurance coverage rate is high in Taiwan, Japan, South Korea, China, Hong Kong, and Singapore; but low in Malaysia and India. This probably affected the use of expensive medications mostly, such as biologics, as we found that the percentage of Crohn's disease (CD) treated with biologics were as high as 30%–40% in Japan, where the government covers all expenses for IBD patients. In India, the percentage maybe as low as 1% for CD patients, most of whom need to pay for the biologics themselves.

Conclusions

There were differences in the public health insurance systems among the Asian countries studied. This reportprovidesthe background information to understand the differences in the treatment of IBD patients among Asian countries.

Citations

Citations to this article as recorded by  
  • Disease experiences and perspectives of adolescent patients with inflammatory bowel disease: a meta-synthesis of qualitative research
    Yue Wang, Fan Guo, Yanrong Xu, Xiaofang Feng, Yueqin Li, Liping Cui
    Frontiers in Public Health.2026;[Epub]     CrossRef
  • Crohn’s Disease in Malaysia: Could Application of the Precautionary Principle Reduce Future Incidence?
    Roger W. Pickup, Pei Boon Ooi, Gaurav Agrawal, Peter M. Atkinson, Jeremy Sanderson, Raja Affendi Raja Ali
    Microorganisms.2026; 14(2): 295.     CrossRef
  • Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition
    Filiz Akyüz, Yoon Kyo An, Jakob Begun, Satimai Aniwan, Huu Hoang Bui, Webber Chan, Chang Hwan Choi, Nazeer Chopdat, Susan J Connor, Devendra Desai, Emma Flanagan, Taku Kobayashi, Allen Yu-Hung Lai, Rupert W Leong, Alex Hwong-Ruey Leow, Wai Keung Leung, Ju
    Intestinal Research.2025; 23(1): 37.     CrossRef
  • Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
    Johannes Hasskamp, Christian Meinhardt, Petrease H Patton, Antje Timmer
    Cochrane Database of Systematic Reviews.2025;[Epub]     CrossRef
  • Affordability issues and the need for a reimbursement process of advanced therapy for inflammatory bowel diseases in India
    Nagesh Kamat, Gaurav Patil, Ankit Dalal, Sanil Parekh, Amit Maydeo
    Current Medical Research and Opinion.2025; 41(6): 959.     CrossRef
  • The rising burden of inflammatory bowel disease in East Asia’s aging population: A cross-sectional study
    Qingbo Yan, Yiyong Chen, Huayu Zhang, Wenping Liu, Jiang Liu
    Medicine.2025; 104(37): e44580.     CrossRef
  • Global Variability in the Management of Inflammatory Bowel Disease: Towards Context-Specific Strategies
    Jeimy M Castellanos, Rachel Cooney
    Cureus.2025;[Epub]     CrossRef
  • Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn’s disease
    Tsubasa Oike, Naoki Akizue, Yuki Ohta, Hirotaka Koseki, Masaya Saito, Yuya Yokoyama, Yushi Imai, Takashi Taida, Kenichiro Okimoto, Keiko Saito, Sadahisa Ogasawara, Tomoaki Matsumura, Tomoo Nakagawa, Makoto Arai, Tatsuro Katsuno, Yoshihiro Fukuda, Yoshio K
    Arab Journal of Gastroenterology.2024; 25(3): 257.     CrossRef
  • Reflections from Chinese and Japanese Physicians on Medical Disputes
    Hua Xu, Yining Ruan, Taketoshi Okita, Masao Tabata, Yasuhiro Kadooka, Atsushi Asai
    Asian Bioethics Review.2024; 16(4): 683.     CrossRef
  • Study of Inflammatory Bowel Disease in Patients Undergoing Colonoscopy at a Tertiary Center of Nepal
    Kumud Bhattarai, Ajit Khanal, Ramila Shrestha, Mukesh S Paudel
    Cureus.2024;[Epub]     CrossRef
  • The treatment of inflammatory bowel disease with monoclonal antibodies in Asia
    Yu Chen, Guolin Zhang, Yuewen Yang, Shuangshuang Zhang, Haozheng Jiang, Kang Tian, Arenbaoligao, Dapeng Chen
    Biomedicine & Pharmacotherapy.2023; 157: 114081.     CrossRef
  • Identification of the informational and supportive needs of patients diagnosed with inflammatory bowel disease: a scoping review
    Narges Norouzkhani, Mahbobeh Faramarzi, Sara Ghodousi Moghadam, Mohammad Amin Karimi, Javad Shokri Shirvani, Ali Bahari, Mahdie ShojaeiBaghini, Saeid Eslami, Hamed Tabesh
    Frontiers in Psychology.2023;[Epub]     CrossRef
  • IBD barriers across the continents – East Asia
    Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
    Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
  • Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South‐East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease‐Emerging Nations' Consortium
    Rupa Banerjee, Partha Pal, Ida Hilmi, Uday C Ghoshal, Devendra C Desai, Mohammed Masudur Rahman, Usha Dutta, Syed A Mohiuddin, Munnera Al Mohannadi, Mathew Philip, Ganesh N Ramesh, Madunil A Niriella, Arjuna P De Silva, Hithanadura Janaka de Silva, Pises
    Journal of Gastroenterology and Hepatology.2022; 37(6): 1004.     CrossRef
  • Managing pediatric psoriasis: update on treatments and challenges—a review
    A. A. Hebert, J. Browning, P. C. Kwong, A. M. Duarte, H. N. Price, E. Siegfried
    Journal of Dermatological Treatment.2022; 33(5): 2433.     CrossRef
  • Landscape of inflammatory bowel disease in Singapore
    Daren Low, Nidhi Swarup, Toshiyuki Okada, Emiko Mizoguchi
    Intestinal Research.2022; 20(3): 291.     CrossRef
  • Inflammatory bowel disease in India: challenges and opportunities
    Alice Snell, Jonathan Segal, Jimmy Limdi, Rupa Banerjee
    Frontline Gastroenterology.2021; 12(5): 390.     CrossRef
  • Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
    Shu-Chen Wei, Jose Sollano, Yee Tak Hui, Wei Yu, Paul V. Santos Estrella, Lyndon John Q. Llamado, Nana Koram
    Expert Review of Gastroenterology & Hepatology.2021; 15(3): 275.     CrossRef
  • Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis—Patients’ and Physicians’ View
    Marla C Dubinsky, Kenji Watanabe, Pauliina Molander, Laurent Peyrin-Biroulet, Michele Rubin, Gil Y Melmed, J Jasper Deuring, John Woolcott, Joseph C Cappelleri, Kathy Steinberg, Susan Connor
    Inflammatory Bowel Diseases.2021; 27(11): 1747.     CrossRef
  • Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn’s Disease in China
    Ting Zhou, Yanan Sheng, Haijing Guan
    Advances in Therapy.2021; 38(8): 4233.     CrossRef
  • Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease
    Rupa Banerjee, Partha Pal, Bhargavi Adigopula, Duvvuru Nageshwar Reddy
    Journal of Clinical Gastroenterology.2021; 55(10): e92.     CrossRef
  • Addressing unmet needs from a new frontier of IBD: the South Asian IBD Alliance
    Tina Aswani-Omprakash, Vishal Sharma, Shrinivas Bishu, Madhura Balasubramaniam, Sumit Bhatia, Neilanjan Nandi, Neha D Shah, Parakkal Deepak, Shaji Sebastian
    The Lancet Gastroenterology & Hepatology.2021; 6(11): 884.     CrossRef
  • Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn’s Disease: A Nationwide Population-Based Study
    Eun Mi Song, Ho-Su Lee, Ye-Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu, Suk-Kyun Yang
    Digestive Diseases and Sciences.2020; 65(4): 1189.     CrossRef
  • Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
    Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
    Digestive Diseases and Sciences.2020; 65(5): 1436.     CrossRef
  • Review of the epidemiology and burden of ulcerative colitis in Latin America
    Paulo Gustavo Kotze, Flavio Steinwurz, Carlos Francisconi, Cyrla Zaltman, Marcia Pinheiro, Leonardo Salese, Dario Ponce de Leon
    Therapeutic Advances in Gastroenterology.2020;[Epub]     CrossRef
  • Optimising management strategies of inflammatory bowel disease in resource-limited settings in Asia
    Siew C Ng, Joyce Wing Yan Mak, Partha Pal, Rupa Banerjee
    The Lancet Gastroenterology & Hepatology.2020; 5(12): 1089.     CrossRef
  • Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
    Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
    Intestinal Research.2019; 17(1): 54.     CrossRef
  • Incidence and clinical impact of perianal disease in patients with ulcerative colitis: A nationwide population‐based study
    Eun Mi Song, Ho‐Su Lee, Ye‐Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang
    Journal of Gastroenterology and Hepatology.2019; 34(6): 1011.     CrossRef
  • Initial medical and surgical management of inflammatory bowel disease in the biologic era: A comparison between the United States and China
    Sanskriti Varma, Jun Hu, Ambar Mehta, Yiran Song, Angela Park, Min Zhi, Susan Hutfless
    JGH Open.2019; 3(3): 234.     CrossRef
  • Regaining normality: A grounded theory study of the illness experiences of Chinese patients living with Crohn’s disease
    Jiayin Ruan, Yunxian Zhou
    International Journal of Nursing Studies.2019; 93: 87.     CrossRef
  • Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
    Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chia
    Journal of Gastroenterology and Hepatology.2019; 34(8): 1296.     CrossRef
  • Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia
    Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chia
    Intestinal Research.2019; 17(3): 285.     CrossRef
  • Stopping anti‐tumour necrosis factor therapy in patients with perianal Crohn’s disease
    Joyce Wing Yan Mak, Whitney Tang, Terry Cheuk Fung Yip, Zhi Hua Ran, Shu Chen Wei, Vineet Ahuja, Sudheer Kumar, Wai Keung Leung, Ida Hilmi, Julajak Limsrivilai, Satimai Aniwan, Belsy C. Y. Lam, Kam Hon Chan, Ka Man Ng, Chi Man Leung, Michael K. K. Li, Fu
    Alimentary Pharmacology & Therapeutics.2019; 50(11-12): 1195.     CrossRef
  • Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea
    Kiju Chang, Ho-Su Lee, Ye-Jee Kim, Seon-Ok Kim, Sung-Han Kim, Sun-Ho Lee, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
    Clinical Gastroenterology and Hepatology.2018; 16(12): 1928.     CrossRef
  • An Intergenic Variant rs9268877 Between HLA-DRA and HLA-DRB Contributes to the Clinical Course and Long-term Outcome of Ulcerative Colitis
    Ho-Su Lee, Suk-Kyun Yang, Myunghee Hong, Seulgi Jung, Byoung Mok Kim, Jung Won Moon, Sang Hyoung Park, Byong Duk Ye, Seak Hee Oh, Kyung Mo Kim, Yong Sik Yoon, Chang Sik Yu, Jiwon Baek, Cue Hyunkyu Lee, Buhm Han, Jianjun Liu, Talin Haritunians, Dermot P B
    Journal of Crohn's and Colitis.2018;[Epub]     CrossRef
  • Paradigm Shift of Healthcare Cost for Patients with Inflammatory Bowel Diseases: A Claims Data-Based Analysis in Japan
    Shota Saito, Kyoko Nakazawa, Kenji Suzuki, Takashi Ishikawa, Kouhei Akazawa
    Gastrointestinal Disorders.2018; 1(1): 120.     CrossRef
  • Overall and cause‐specific mortality in Korean patients with inflammatory bowel disease: A hospital‐based cohort study
    Ho‐Su Lee, Jaewon Choe, Seon‐Ok Kim, Sun‐Ho Lee, Hyo Jeong Lee, Hyungil Seo, Gwang‐Un Kim, Myeongsook Seo, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Kyung‐Jo Kim, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Yong Sik Yoon, Chang S
    Journal of Gastroenterology and Hepatology.2017; 32(4): 782.     CrossRef
  • Emerging biologics in inflammatory bowel disease
    Heyson Chi-hey Chan, Siew Chien Ng
    Journal of Gastroenterology.2017; 52(2): 141.     CrossRef
  • Balloon-Assisted Enteroscopy and Capsule Endoscopy in Suspected Small Bowel Crohn’s Disease
    Hsu-Heng Yen, Chen-Wang Chang, Jen-Wei Chou, Shu-Chen Wei
    Clinical Endoscopy.2017; 50(5): 417.     CrossRef
  • Pivot to Asia: inflammatory bowel disease burden
    Prashant Singh, Ashwin Ananthakrishnan, Vineet Ahuja
    Intestinal Research.2017; 15(1): 138.     CrossRef
  • Short-Term Clinical Response to Corticosteroids Can Predict Long-Term Natural History of Ulcerative Colitis: Prospective Study Experience
    Tarun Rai, Bikash Narayan Choudhury, Saurabh Kedia, Sawan Bopanna, Pratap Mouli Venigalla, Sushil Kumar Garg, Vikas Singla, Govind Makharia, Vineet Ahuja
    Digestive Diseases and Sciences.2017; 62(4): 1025.     CrossRef
  • Results of the first survey for the current status of inflammatory bowel disease management in Asian countries
    Ji Won Kim
    Intestinal Research.2016; 14(3): 199.     CrossRef
  • 21,748 View
  • 84 Download
  • 40 Web of Science
  • 42 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP